These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11685754)
21. High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization. Sundblad BM; Larsson K; Nathell L Nicotine Tob Res; 2008 May; 10(5):883-90. PubMed ID: 18569763 [TBL] [Abstract][Full Text] [Related]
22. Pharmacotherapy of tobacco dependence. Talwar A; Jain M; Vijayan VK Med Clin North Am; 2004 Nov; 88(6):1517-34. PubMed ID: 15464111 [TBL] [Abstract][Full Text] [Related]
23. [Smoking reduction and temporary abstinence: new approaches for smoking cessation]. Le Houezec J; Säwe U J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435 [TBL] [Abstract][Full Text] [Related]
25. Combined nicotine replacement therapy provides best chance of smoking cessation. Harv Ment Health Lett; 2010 Feb; 26(8):7. PubMed ID: 20235378 [No Abstract] [Full Text] [Related]
26. Developments in pharmacotherapy for tobacco dependence: past, present and future. Foulds J; Steinberg MB; Williams JM; Ziedonis DM Drug Alcohol Rev; 2006 Jan; 25(1):59-71. PubMed ID: 16492578 [TBL] [Abstract][Full Text] [Related]
27. [Smoking cessation with special focus on primary health care]. Bredesen H; Lous J Ugeskr Laeger; 2009 Feb; 171(9):683-8. PubMed ID: 19257992 [TBL] [Abstract][Full Text] [Related]
28. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua. Lutz MA; Lovato P; Cuesta G Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881 [TBL] [Abstract][Full Text] [Related]
29. National trends in the provision of smoking cessation aids within the Veterans Health Administration. Jonk YC; Sherman SE; Fu SS; Hamlett-Berry KW; Geraci MC; Joseph AM Am J Manag Care; 2005 Feb; 11(2):77-85. PubMed ID: 15726855 [TBL] [Abstract][Full Text] [Related]
30. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological aids for smoking cessation. Ho K; Abourjaily HM J Mass Dent Soc; 2001; 50(1):30-3, 47. PubMed ID: 11326710 [TBL] [Abstract][Full Text] [Related]
32. [Methods and cost effectiveness of nicotine abstinence]. Górecka D Pol Merkur Lekarski; 2004 May; 16 Suppl 1():79-82. PubMed ID: 15524024 [TBL] [Abstract][Full Text] [Related]
33. Pharmacotherapies to enhance smoking cessation during pregnancy. Oncken CA; Kranzler HR Drug Alcohol Rev; 2003 Jun; 22(2):191-202. PubMed ID: 12850906 [TBL] [Abstract][Full Text] [Related]
34. A comparison of sustained-release bupropion and placebo for smoking cessation. Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378 [TBL] [Abstract][Full Text] [Related]
35. [Current and future medical drugs for smoking cessation]. Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of the first-line therapies for nicotine dependence. Cornuz J; Pinget C; Gilbert A; Paccaud F Eur J Clin Pharmacol; 2003 Jul; 59(3):201-6. PubMed ID: 12759795 [TBL] [Abstract][Full Text] [Related]